DrugPatentWatch Database Preview
Profile for Montenegro Patent: P50808
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Montenegro Patent: P50808
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 10, 2029 | Boehringer Ingelheim | GILOTRIF | afatinib dimaleate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |